BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22287726)

  • 1. Tumor interstitial fluid as modulator of cancer inflammation, thrombosis, immunity and angiogenesis.
    Baronzio G; Schwartz L; Kiselevsky M; Guais A; Sanders E; Milanesi G; Baronzio M; Freitas I
    Anticancer Res; 2012 Feb; 32(2):405-14. PubMed ID: 22287726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor interstitial fluid: proteomic determination as a possible source of biomarkers.
    Baronzio G; Parmar G; Baronzio M; Kiselevsky M
    Cancer Genomics Proteomics; 2014; 11(5):225-37. PubMed ID: 25331795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer.
    Wiig H; Swartz MA
    Physiol Rev; 2012 Jul; 92(3):1005-60. PubMed ID: 22811424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems.
    Wu M; Frieboes HB; McDougall SR; Chaplain MA; Cristini V; Lowengrub J
    J Theor Biol; 2013 Mar; 320():131-51. PubMed ID: 23220211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor interstitial fluid promotes malignant phenotypes of lung cancer independently of angiogenesis.
    Li H; Li G; Liu L; Guo Z; Ma X; Cao N; Lin H; Han G; Duan Y; Du G
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1120-9. PubMed ID: 26342025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed.
    ten Hagen TL; Seynhaeve AL; Eggermont AM
    Immunol Rev; 2008 Apr; 222():299-315. PubMed ID: 18364010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor interstitial fluid: misconsidered component of the internal milieu of a solid tumor.
    Freitas I; Baronzio GF; Bono B; Griffini P; Bertone V; Sonzini N; Magrassi GR; Bonandrini L; Gerzeli G
    Anticancer Res; 1997; 17(1A):165-72. PubMed ID: 9066647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesis.
    Lunt SJ; Fyles A; Hill RP; Milosevic M
    Future Oncol; 2008 Dec; 4(6):793-802. PubMed ID: 19086846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation.
    Mantovani A; Sica A; Allavena P; Garlanda C; Locati M
    Hum Immunol; 2009 May; 70(5):325-30. PubMed ID: 19236898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Swords into plowshares: IL-23 repurposes tumor immune surveillance.
    Langowski JL; Kastelein RA; Oft M
    Trends Immunol; 2007 May; 28(5):207-12. PubMed ID: 17395538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphangiogenesis, inflammation and metastasis.
    Schoppmann SF
    Anticancer Res; 2005; 25(6C):4503-11. PubMed ID: 16334134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the microenvironment and intercellular cross-talk in tumor angiogenesis.
    Jung YD; Ahmad SA; Liu W; Reinmuth N; Parikh A; Stoeltzing O; Fan F; Ellis LM
    Semin Cancer Biol; 2002 Apr; 12(2):105-12. PubMed ID: 12027582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial Fluid in Gynecologic Tumors and Its Possible Application in the Clinical Practice.
    Ura B; Di Lorenzo G; Romano F; Monasta L; Mirenda G; Scrimin F; Ricci G
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the Tumor Secretome from Tumor Interstitial Fluid (TIF).
    Gromov P; Gromova I
    Methods Mol Biol; 2016; 1459():231-47. PubMed ID: 27665563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor and its relationship to inflammatory mediators.
    Angelo LS; Kurzrock R
    Clin Cancer Res; 2007 May; 13(10):2825-30. PubMed ID: 17504979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF).
    Ferreira MA; Barcelos LS; Teixeira MM; Bakhle YS; Andrade SP
    Life Sci; 2007 Jun; 81(3):210-7. PubMed ID: 17588613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of protein clusters predictive of response to chemotherapy in breast cancer patients.
    Cortesi L; Barchetti A; De Matteis E; Rossi E; Della Casa L; Marcheselli L; Tazzioli G; Lazzaretti MG; Ficarra G; Federico M; Iannone A
    J Proteome Res; 2009 Nov; 8(11):4916-33. PubMed ID: 19739612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Numerical simulation of the tumor interstitial fluid transport: Consideration of drug delivery mechanism.
    Moghadam MC; Deyranlou A; Sharifi A; Niazmand H
    Microvasc Res; 2015 Sep; 101():62-71. PubMed ID: 26122936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular heterogeneity of tumor endothelium.
    Aird WC
    Cell Tissue Res; 2009 Jan; 335(1):271-81. PubMed ID: 18726119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.